BDBV289-N possessed equivalent binding activity to EBOV GP in comparison with the initial mAb expressed from hybridoma cells (Supplementary Body 1)
BDBV289-N possessed equivalent binding activity to EBOV GP in comparison with the initial mAb expressed from hybridoma cells (Supplementary Body